Long term toxicity of treatment. Laurence Brugieres Children and Adolescent Oncologic department

Size: px
Start display at page:

Download "Long term toxicity of treatment. Laurence Brugieres Children and Adolescent Oncologic department"

Transcription

1 Long term toxicity of treatment Laurence Brugieres Children and Adolescent Oncologic department

2 Most TYA with cancer are cured from their malignancy TRAMA

3 What are the consequences of cancer treatment? Many studies have shown an excess of morbidity and mortality in survivors of cancers especially after a cancer in children and adolescents 75% of survivors after childhood cancer have a least one chronic condition in adulthood Mortality risk is increased mostly by > Second malignancies > Cardiovascular complications > Lung disease Hudson, JAMA, 2013 Reulen, JAMA,

4 Long-term consequences of cancer treatment Second malignancies Cardiotoxicity Strokes Nephrotoxicity Fertility impairement Metabolic syndrome and endocrine disorders Neurotoxicity Ototoxicity Fatigue Cognitive impairment Psychosocial issues 25/05/2018 Long term follow-up 4

5 Second malignancies 5

6 patients treated between for selected malignancies > primary acute leukemia (lymphoblastic, myelogenous, or unspecified), > lymphoma (Hodgkin and non-hodgkin), > germ cell tumors (ovarian or testicular), > thyroid cancer, > melanoma, > breast cancer, > sarcomas (soft tissue sarcomas or malignant bone tumors) 25/05/2018 Long term follow-up 6

7 30 year after the 1 st cancer, 13.9% pts with 2 nd cancer Cumulative incidence survivors at 5 years Treated between 1970 et 2011 Age < 15 y y > 40 y Lee, Cancer, may 2018 Median time to second malignancies 16 y in children. 15 y in TYA 10 y in older adults 7

8 Second malignancies : role of treatment 17% 12% Lee et al 25/05/2018 Long term follow-up 8

9 Impact of radiotherapy effect of high-dose irradiation : linear dose-response for most organs but important organ- and host-specific differences 25/05/2018 Long term follow-up 9

10 Cranial irradiation and secondary meningioma and glioma Relative risks at Gy Meningioma ( ): 96.3 Glioma ( ): 21 Neglia, JNCI, /05/2016 Long-term follow-up of childhood cancer survivors with brain tumors 10

11 Seconds maligancies : impact of the dose of radiotherapy Risk of thyroid cancer Risk x15 à Gy Veiga, Radiat Res,

12 Second cancer : impact of radiotherapy Breast cancer Risk x6 à 20 Gy Risk x12 à 40 Gy Inskip, JCO, mars 2017 EFEC - Clinique de Suivi à Long Terme en Oncologie Pédiatrique 12

13 Second malignancies after Hodgkin s lymphoma Risk of cancer increased by 2.39 Cumulative incidence of 13.9 % in males and 24% in females pts treated in Sweeden between 1966 and 2012 Median FU : 12.6 y 1121 second malignancies Sud, JCO 2017

14 Second malignancies after Hodgkin in patients < 35 y at diagnosis males Females Colon lung breast skin NHL leukemia Colon Lung Breast Skin NHL leukemai Cumulative risk at 30 y : 13.9% Cumulative risk at 30 y : 24.5 % for all cancers 13.8% for breast Sud JCO /05/2018 Long term follow-up 14

15 Role of familial history of cancer Risk of second malignancy significantly higher in patients with familial history of cancer

16 Cancer predisposition and subsequent neoplasms in CNS survivors 2779 childhood CNS tumor survivors from St Jude ( ) 81 survivors had 97 subsequent neoplasms SN (64 malignant) 22% had a cancer predisposition syndrome > 3 children with Gorlin syndrome 11 SNs > 9 children with neurofibromatosis type 1 11 SNs > 2 children with Li Fraumeni syndrome 1 SN each > 1 child with neurofibromatosis type 2 1 SN > 1 child with Lynch syndrome 1 SN > 1 child with familial adenomatous polyposis 1 SN > 1 child with Fanconi anemia 1 SN Tsui, Neuro Onco, /05/

17 Guidelines for screening after the end of oncologic follow-up Brain irradiation : brain MRI/ 5 y Cervical irradiation : thyroid ultrasound/5 y Breast irradiation > Gy : > annual screnning beginning at 25 and 8 y after the end of radiotherapy > palpation, ultrasound, MRI and mammo after 35 y In all patients after radiation annual dermatologic examination These guidelines should be adapted to genetic background 17

18 5- Fertility impairement 12 mai

19 Fertility imparirement Concerns both men and women Related to anti cancer treatment > Chemotherapy : ALKYLATING agent > Radiotherapy (ovary, testis, hypophyse) > Surgery 28 mars 2017 EFEC - Clinique de Suivi à Long Terme en Oncologie Pédiatrique 19

20 10938 survivors and 3948 siblings Median follow-up 10 years Decreased likelihood of having lifebirth in survivors vs siblings > male survivors: hazard ratio HR 0 63, ; p< > female survivors HR 0 82, ; p< Risk factors > Males : Cyclophosphamide, ifosfamide, procarbazine, cisplatinum > Females : Busulfan, lomustine > 411 mg/m 2, cyclophosphamide > 7,4 g/m 2 25/05/2018 Long term follow-up 20

21 Cyclophosphamide and male fertility 10.8 g/m² 8.5 g/m² 6.6 g/m² Normospermia 89% si Cyclo < 4 g/m² Green, Lancet onco,

22 Risk of ovarian failure according to age 25/05/2018 Long term follow-up 22

23 Cumulative incidence of premature menopause after Hodgkin lymphoma Risk of premature menopause at 5 y : - 52% after RT 5 gy to ovary - 51% after BEAM - 24% after 6 cycles including AA - Increased in older patients Cumulative risk of premature menopause before 40 y - 81% after > 5 Gy on ovary - 75% after BEAM - 49% after > 6 cycles including AA - 1.4% after ABVD - 3% after susdiaphragmatic RT Swerdlow 2014

24 Ovary radiosensiitivity Dose delivered to ovary leading to infertility Anderson, Lancet diab endoc, mars 2017 EFEC - Clinique de Suivi à Long Terme en Oncologie Pédiatrique 24

25 Organization of long term follow-up 25/05/2018 Long term follow-up 25

26 Long term follow-up of adults survivors of cancer in childhood aiming to Give information on long-term side effects of cancer treatment Propose individualized guidelines for screening for complications according to previous treatment and individual risk factors Improve early detection of complications Set up a network of experts adapted to the patients needs especially for patienst requiring sevral specialists (such as cardiologists, nephrologists, orthopedic surgeons, ) 26

27 Long term follow-up clinic Gustave Roussy 27

28 How can we organize such a follow-up in adults? 28

Second Neoplasms Working Group. CCSS Investigators Meeting June 2017

Second Neoplasms Working Group. CCSS Investigators Meeting June 2017 Second Neoplasms Working Group CCSS Investigators Meeting June 2017 Second Neoplasms Working Group Overview Ongoing review, adjudication and entry of reported neoplasms into data set Initial review of

More information

PEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP. Denise Rokitka, MD, MPH

PEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP. Denise Rokitka, MD, MPH PEDIATRIC & ADOLESCENT CANCER SURVIVORSHIP Denise Rokitka, MD, MPH Objectives Describe incidence of childhood cancer and survival rates and causes of early mortality. Understand the late effects of cancer

More information

Cancer Prevention & Control in Adolescent & Young Adult Survivors

Cancer Prevention & Control in Adolescent & Young Adult Survivors + Cancer Prevention & Control in Adolescent & Young Adult Survivors NCPF Workshop July 15-16, 2013 Patricia A. Ganz, MD UCLA Schools of Medicine & Public Health Jonsson Comprehensive Cancer Center + Overview

More information

Αdverse effects of chemotherapy and radiotherapy

Αdverse effects of chemotherapy and radiotherapy Αdverse effects of chemotherapy and radiotherapy Giannis Mountzios MSc, PhD Medical Oncologist 251 General Aiforce Hospital 2 nd Oncology Department, Henry Dunant Hospital Centre Athens, Greece ESMO Preceptorship

More information

Cancer in adolescents and Young Adults

Cancer in adolescents and Young Adults 17 th ESO-ESMO Masterclass in Clinical Oncology 24-29 March 2018, Cancer in adolescents and Young Adults Laurence Brugières Gustave Roussy Cancer Center Villejuif, France Cancer in TYA A rare disease in

More information

Evidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors.

Evidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors. Evidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors. Who needs surveillance? Chiarelli et al. Early menopause and Infertility

More information

Medical Late Effects of Childhood Cancer

Medical Late Effects of Childhood Cancer Medical Late Effects of Childhood Cancer Robert Goldsby Associate Professor of Clinical Pediatric UCSF Late Mortality in 5+ Year Survivors 1.00 US Female US Male Survival function estimate 0.70 0.75 0.80

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Schaapveld M, Aleman BMP, van Eggermond AM, et al. Second cancer

More information

The Adolescent: A Patient at Risk: Ovarian Failure in Adolescent Cancer Survivors

The Adolescent: A Patient at Risk: Ovarian Failure in Adolescent Cancer Survivors The Adolescent: A Patient at Risk: Ovarian Failure in Adolescent Cancer Survivors Avner Hershlag MD Professor and Chief Center for Human Reproduction North Shore LIJ Hofsra university School of Medicine

More information

CCSS Neurology Committee Report: 6/08

CCSS Neurology Committee Report: 6/08 Neurology Committee Report: 6/08 Roger J. Packer, MD Executive Director Neuroscience and Behavioral Medicine Chairman, Neurology Director, Brain Tumor Institute Children s s National Medical Center Washington,

More information

Cancer and Fertility Ashley Munchel, MD Assistant Professor of Pediatrics University of Maryland Medical Center

Cancer and Fertility Ashley Munchel, MD Assistant Professor of Pediatrics University of Maryland Medical Center Cancer and Fertility Ashley Munchel, MD Assistant Professor of Pediatrics University of Maryland Medical Center Trends in Pediatric Cancer Incidence Rates by Site, Ages Birth to 19 Years, 1975 to 2010.

More information

CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL

CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL 1. Study title: Subsequent neoplasms among survivors of childhood cancer not previously treated with radiation 2. Working group and investigators:

More information

Why? What? When? How? Dr C Fryer FRCPC) Surveillance

Why? What? When? How? Dr C Fryer FRCPC) Surveillance Why? What? When? How? Dr C Fryer FRCPC) Surveillance 1 Disclosure; Disclosure; None. I have no conflicts. I have no industry financial relationships. Background: Relapse is the single most likely late

More information

Τhe unique constellation of tumors in AYA: Not an adult, not a child

Τhe unique constellation of tumors in AYA: Not an adult, not a child Τhe unique constellation of tumors in AYA: Not an adult, not a child Giannis Mountzios MSc, PhD Medical Oncologist 251 General Aiforce Hospital 2 nd Oncology Department, Henry Dunant Hospital Centre Athens,

More information

Disclosures. This presentation is the intellectual property of the author. Contact them for permission to reprint and/or distribute.

Disclosures. This presentation is the intellectual property of the author. Contact them for permission to reprint and/or distribute. ALL in AYAs: Health Outcomes as a Criterion for Selecting Optimal Therapy David R. Freyer, DO, MS Director, Survivorship and Supportive Care Program, Children s Center for Cancer and Blood Diseases, Children

More information

Optimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE

Optimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE Optimizing Fertility and Wellness After Cancer Kat Lin, MD, MSCE University Reproductive Care University of Washington Nov. 6, 2010 Optimism in Numbers 5-year survival rate 78% for all childhood cancers

More information

Prevention and screening of long term side effects. Lena Specht MD DMSc Professor of Oncology Rigshospitalet, University of Copenhagen Denmark

Prevention and screening of long term side effects. Lena Specht MD DMSc Professor of Oncology Rigshospitalet, University of Copenhagen Denmark Prevention and screening of long term side effects Lena Specht MD DMSc Professor of Oncology Rigshospitalet, University of Copenhagen Denmark Disclosures Member of Advisory Board and Principal Investigator,

More information

Late Effects in Pediatric Cancer Survivors

Late Effects in Pediatric Cancer Survivors Late Effects in Pediatric Cancer Survivors LISA K OPP, DO ASSOCIATE PROFESSOR THE UNIVERSITY OF ARIZONA DEPARTMENT OF PEDIATRICS DIVISION OF HEMATOLOGY/ONCOLOGY/BMT Objectives Review Childhood Cancer and

More information

Survival in Teenagers and Young. Adults with Cancer in the UK

Survival in Teenagers and Young. Adults with Cancer in the UK Survival in Teenagers and Young Adults with Cancer in the UK Survival in Teenagers and Young Adults (TYA) with Cancer in the UK A comparative report comparing TYA cancer survival with that of children

More information

Childhood Cancer Survivor Study Analysis Concept Proposal

Childhood Cancer Survivor Study Analysis Concept Proposal Title: Multiple Subsequent Neoplasms Working Group and Investigators: Childhood Cancer Survivor Study Analysis Concept Proposal This proposed publication will be within the Second Malignancy Working Group

More information

IAEA Pediatric Radiation Oncology Training Dr Laskar Version 1 June 2009 RADIATION THERAPY FOR PEDIATRIC HODGKIN S DISEASE

IAEA Pediatric Radiation Oncology Training Dr Laskar Version 1 June 2009 RADIATION THERAPY FOR PEDIATRIC HODGKIN S DISEASE RADIATION THERAPY FOR PEDIATRIC HODGKIN S DISEASE THOMAS HODGKIN 1832 On Some Morbid Appearances of the Absorbent Glands & Spleen GLOBAL INCIDENCE Region Cases per 100,000 children United States 0.5 European

More information

Pediatric Oncology. Vlad Radulescu, MD

Pediatric Oncology. Vlad Radulescu, MD Pediatric Oncology Vlad Radulescu, MD Objectives Review the epidemiology of childhood cancer Discuss the presenting signs and symptoms, general treatment principles and overall prognosis of the most common

More information

Chronic Disease Working Group CCSS Investigator Meeting 2015

Chronic Disease Working Group CCSS Investigator Meeting 2015 Chronic Disease Working Group CCSS Investigator Meeting 2015 Kevin Oeffinger Charles (Chuck) Sklar Chronic Disease Working Group Next 10 yrs of CCSS may be more significant than the previous 10 yrs CCSS

More information

Disturbances of female reproductive system in survivors of childhood cancer

Disturbances of female reproductive system in survivors of childhood cancer Disturbances of female reproductive system in survivors of childhood cancer Assoc. Prof. Zana Bumbuliene VU Faculty of Medicine Clinic of Obstetrics and Gynaecology 13 SEP 2014 Introduction Cancer is the

More information

3. BACKGROUND AND RATIONALE

3. BACKGROUND AND RATIONALE CHILDHOOD CANCER SURVIVOR STUDY Revised Analysis Concept Proposal 10-17 October 12, 2011 1. STUDY TITLE: Growth Hormone Exposure as a risk factor for the development of Subsequent Central Nervous System

More information

SURVIVORSHIP WITH LYMPHOMA APRIL SHAMY MD,CM JEWISH GENERAL HOSPITAL MCGILL UNIVERSITY

SURVIVORSHIP WITH LYMPHOMA APRIL SHAMY MD,CM JEWISH GENERAL HOSPITAL MCGILL UNIVERSITY SURVIVORSHIP WITH LYMPHOMA APRIL SHAMY MD,CM JEWISH GENERAL HOSPITAL MCGILL UNIVERSITY Some Statistics Approximately 1 in 2 Canadians develop cancer 25% of Canadians die of cancer 2009: 810,000 Canadians

More information

The issue of second malignancies. Risks associated with radiotherapy UCL

The issue of second malignancies. Risks associated with radiotherapy UCL The issue of second malignancies Risks associated with radiotherapy Spinocellular carcinoma of a dentist's finger QuickTime et un module de décompression QuickTime et to CD sont requis pour visualiser

More information

1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor Study.

1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor Study. CCSS Analysis Concept Proposal Exercise, Mortality, & Childhood Cancer 1 1. Study Title. Exercise and Late Mortality in 5-Year Survivors of Childhood Cancer: a Report from the Childhood Cancer Survivor

More information

Adolescents & Young Adults with Cancer

Adolescents & Young Adults with Cancer Adolescents & Young Adults with Cancer April 2017 Technical Appendix Page 1 of 11 Cancer incidence rate Age-standardized incidence rates per 100,000 population for different cancers in adolescents & young

More information

Epidemiology of AYA tumours. Dan Stark, MD Consultant in Medical Oncology Leeds UK

Epidemiology of AYA tumours. Dan Stark, MD Consultant in Medical Oncology Leeds UK Epidemiology of AYA tumours Dan Stark, MD Consultant in Medical Oncology Leeds UK Summary Why we should study the epidemiology of AYA tumours What is already known What is not already known and is important

More information

Reproductive function in cancer survivors

Reproductive function in cancer survivors Reproductive function in cancer survivors Professor W Hamish Wallace hamish.wallace@nhs.net Symposium 20: Endocrine consequences of childhood cancer treatment Liffey Hall 2, 0905 19 May 2015 CONFLICT OF

More information

Female Health Issues after Treatment for Childhood Cancer

Female Health Issues after Treatment for Childhood Cancer Female Health Issues after Treatment for Childhood Cancer The effects of childhood cancer therapy on female reproductive function depend on many factors, including the girl s age at the time of cancer

More information

Childhood Cancer Survivor Study Study Proposal: Male Health Questionnaire (MHQ) and CED February 2015

Childhood Cancer Survivor Study Study Proposal: Male Health Questionnaire (MHQ) and CED February 2015 Childhood Cancer Survivor Study Study Proposal: Male Health Questionnaire (MHQ) and CED February 2015 1. STUDY TITLE: Cyclophosphamide Equivalent Dosing and Male Health Late Effects Infertility, Erectile

More information

Exercise Behavior & Major Cardiac Events: CCSS 1 STUDY TITLE

Exercise Behavior & Major Cardiac Events: CCSS 1 STUDY TITLE STUDY TITLE Exercise Behavior & Major Cardiac Events: CCSS 1 Association Between Exercise Behavior and Incidence of Major Cardiac Events in Adult Survivors of Childhood Cancer: A Report from the Childhood

More information

The effects of cancer treatment on male infertility

The effects of cancer treatment on male infertility The effects of cancer treatment on male infertility Kirsi Jahnukainen Children s Hospital, Helsinki Karolinska Institutet, Stockholm Department of Pediatrics 21.11.2017 1 Disclosure statement I declare

More information

Endocrine Late Effects in Survivors of Pediatric SCT

Endocrine Late Effects in Survivors of Pediatric SCT Endocrine Late Effects in Survivors of Pediatric SCT Daphna Hutt Pediatric Hem-Onc & BMT Sheba Medical Center, Israel #EBMT2015 www.ebmt.org Stiller CA (2007). Childhood Cancer In Britain. Oxford University

More information

Childhood Cancer Survivor Study Analysis Concept Proposal. Title: Analysis of Late Mortality by Treatment Era.

Childhood Cancer Survivor Study Analysis Concept Proposal. Title: Analysis of Late Mortality by Treatment Era. Childhood Cancer Survivor Study Analysis Concept Proposal Title: Analysis of Late Mortality by Treatment Era Working Group & Investigators: Greg Armstrong Todd Gibson Ann Mertens Wendy Leisenring YutakaYasui

More information

Childhood Cancer Survivor study Study Proposal: Chronic Endocrine Disorders in Cancer Survivors February 2014

Childhood Cancer Survivor study Study Proposal: Chronic Endocrine Disorders in Cancer Survivors February 2014 Childhood Cancer Survivor study Study Proposal: Chronic Endocrine Disorders in Cancer Survivors February 2014 1. STUDY TITLE: Chronic endocrine disorders in adult survivors of childhood cancer: A Report

More information

Childhood Cancer Survivor Study Analysis Concept Proposal

Childhood Cancer Survivor Study Analysis Concept Proposal Childhood Cancer Survivor Study Analysis Concept Proposal Title: Long-Term Outcomes of Childhood Central Nervous System Tumor Survivors: A Report from the Childhood Cancer Survivor Study Working Group

More information

Radiation and Hodgkin s Disease: A Changing Field. Sravana Chennupati Radiation Oncology PGY-2

Radiation and Hodgkin s Disease: A Changing Field. Sravana Chennupati Radiation Oncology PGY-2 Radiation and Hodgkin s Disease: A Changing Field Sravana Chennupati Radiation Oncology PGY-2 History of Present Illness 19 yo previously healthy male college student began having pain in his R shoulder

More information

Updated Analysis of Non-Surgical Premature Menopause in the Childhood Cancer Survivor Study

Updated Analysis of Non-Surgical Premature Menopause in the Childhood Cancer Survivor Study Analysis Concept Proposal 1. Study Title Updated Analysis of Non-Surgical Premature Menopause in the Childhood Cancer Survivor Study 2. Working Group and Investigators CCSS Working Group: Chronic Disease

More information

Female Gonadal Toxicity Surveillance Harmonization: Formulation of Recommendations

Female Gonadal Toxicity Surveillance Harmonization: Formulation of Recommendations Female Gonadal Toxicity Surveillance Harmonization: Formulation of Recommendations Chair: Riccardo Haupt (I) Hamish Wallace (UK) Coordinator: Wendy van Dorp (NL) Guideline KNOWLEDGE/ EVIDENCE RECOMMENDATION

More information

Macmillan Publications

Macmillan Publications S1 S2 S3 S3 S3 S4 S5 S6 S7 S8 S8 S9 S10 S11 S11 S12 S13 S14 S15 S17 S18 S19 Bladder Cancer: Non-Invasive, Invasive and Advanced Bone Cancer: Primary, Secondary Colon Cancer, Anal Cancer, Rectal Cancer

More information

Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study Sogol Mostoufi-Moab, University of Pennsylvania Kristy Seidel, Fred Hutchinson Cancer Research

More information

Cancer survivorship. What is survivorship? Issues after cancer treatment Cancer and beyond Co-survivorship 06/02/2018

Cancer survivorship. What is survivorship? Issues after cancer treatment Cancer and beyond Co-survivorship 06/02/2018 Cancer survivorship Helen Hatcher and TV Ajithkumar Cambridge University Hospitals NHS Trust What is survivorship? Issues after cancer treatment Cancer and beyond Co-survivorship 1 Survivorship The time

More information

The Current Pediatric Oncology Landscape

The Current Pediatric Oncology Landscape The Current Pediatric Oncology Landscape An Imperative for Change Smita Bhatia, MD, MPH UAB Department of Pediatrics at Children s Hospital of Alabama Five-year Observed Survival Rates for Two Time Periods,

More information

SAMPLE. Survivorship Care Plan for Lymphoma (Diffuse Large B-Cell) General Information. Care team

SAMPLE. Survivorship Care Plan for Lymphoma (Diffuse Large B-Cell) General Information. Care team SAMPLE This Survivorship Care Plan will facilitate cancer care following active treatment. It may include important contact information, a treatment summary, recommendations for follow-up care testing,

More information

5/2/2016. Caring for Adolescents and Young Adults with Cancer. Objectives. AYA Oncology. Cancer Incidence: SEER 18, , ages

5/2/2016. Caring for Adolescents and Young Adults with Cancer. Objectives. AYA Oncology. Cancer Incidence: SEER 18, , ages Objectives Caring for Adolescents and Young Adults with Cancer Oncology Nursing: Planting Seeds of Hope and Healing May 4 th, 2016 Describe distinctive aspects of disease biology in AYA population List

More information

Overview of 2010 Hong Kong Cancer Statistics

Overview of 2010 Hong Kong Cancer Statistics Overview of 2010 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since the 1960s been providing population-based cancer data for epidemiological research

More information

Title: Incidence of chronic disease among childhood cancer survivors by treatment era and temporal trends in treatment exposure

Title: Incidence of chronic disease among childhood cancer survivors by treatment era and temporal trends in treatment exposure Childhood Cancer Survivor Study Analysis Concept Proposal Title: Incidence of chronic disease among childhood cancer survivors by treatment era and temporal trends in treatment exposure Working Group &

More information

Burden of Cancer in California

Burden of Cancer in California Burden of Cancer in California California Cancer Reporting and Epidemiologic Surveillance Institute for Population Health Improvement UC Davis Health August 22, 2018 Outline 1. Incidence and Mortality

More information

Chapter 4. Managing Fertility in Childhood Cancer Patients T.K. Woodruff and K.A. Snyder (eds.) Oncofertility. Springer 2007

Chapter 4. Managing Fertility in Childhood Cancer Patients T.K. Woodruff and K.A. Snyder (eds.) Oncofertility. Springer 2007 Chapter 4 Managing Fertility in Childhood Cancer Patients T.K. Woodruff and K.A. Snyder (eds.) Oncofertility. Springer 2007 The original publication of this article is available at www.springerlink.com

More information

Childhood Cancer Survivor Study (U24 CA55727)

Childhood Cancer Survivor Study (U24 CA55727) CCSS An NCI-funded Resource Childhood Cancer Survivor Study (U24 CA55727) Report of the Chronic Disease Working Group Charles Sklar, M.D. CCSS Investigator Meeting Williamsburg, VA June 9-10, 2010 Chronic

More information

AYA & XYZ: Care of the Childhood Cancer Survivor & Adolescent/Young Adult Oncology

AYA & XYZ: Care of the Childhood Cancer Survivor & Adolescent/Young Adult Oncology AYA & XYZ: Care of the Childhood Cancer Survivor & Adolescent/Young Adult Oncology ST E P H A N I E H O W E G UA R I N O, M D, MSHP, FA A P S I C K L E C E L L PROGRAM C L I N I CAL L EAD, C H R I ST I

More information

Cancer: recent advances and implications for underwriting

Cancer: recent advances and implications for underwriting Cancer: recent advances and implications for underwriting Robert Rubens Select 74 Bristol 25 February 2010 Agenda Epidemiology - changing mortality Evidence-base for underwriting breast cancer ovarian

More information

Female Health Issues after Treatment for Childhood Cancer

Female Health Issues after Treatment for Childhood Cancer after Treatment for Childhood Cancer The effects of childhood cancer therapy on female reproductive function depend on many factors, including the girl s age at the time of cancer therapy, the specific

More information

Long Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer

Long Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer Global Breast Cancer Conference 2017 21 st Apr, 2017@Chezu Island Long Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer Shinji Ohno, M.D., Ph.D., F.A.C.S. Breast

More information

CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL

CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL STUDY TITLE: Infertility and the use of fertility treatments in female survivors of childhood cancer. WORKING GROUP Chronic Disease INVESTIGATORS:

More information

Fertility preservation in the (young) cancer patient

Fertility preservation in the (young) cancer patient Fertility preservation in the (young) cancer patient Professor W Hamish B Wallace University of Edinburgh & Royal Hospital for Sick Children, Edinburgh, Scotland, UK hamish.wallace@nhs.net ESMO Madrid

More information

CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal

CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal CHILDHOOD CANCER SURVIVOR STUDY Analysis Concept Proposal 1. TITLE: Follow-Up of Long Term Survivors of Hodgkin s Disease Diagnosed in Childhood and Adolescence A Report from the Childhood Cancer Survivors

More information

a) Study Title: The impact of chronic disease on health care utilization in the CCSS cohort

a) Study Title: The impact of chronic disease on health care utilization in the CCSS cohort Analysis Concept Proposal a) Study Title: The impact of chronic disease on health care utilization in the CCSS cohort b) Working Group Investigators This proposed project will be developed through the

More information

Breast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity

Breast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity Breast Cancer in Childhood Cancer Survivors: The Impact of Screening on Morbidity WORKING GROUP: This report will be written within the Cancer Control Working Group with oversight from the Second Malignant

More information

Hormone Deficiencies in Cancer Survivors MEMS Annual Congress (MAC) May 2013

Hormone Deficiencies in Cancer Survivors MEMS Annual Congress (MAC) May 2013 Hormone Deficiencies in Cancer Survivors MEMS Annual Congress (MAC) 2013 24-27 May 2013 Dr. Fuziah Md. Zain Paediatric Department Content Introduction Chronic health problems late effects Endocrine late

More information

CHILDHOOD CANER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL

CHILDHOOD CANER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL CHILDHOOD CANER SURVIVOR STUDY ANALYSIS CONCEPT PROPOSAL Project Title: Comparison of risks of mortality (all-cause, cause-specific) and invasive second or subsequent cancers: a Childhood Cancer Survivor

More information

Childhood Cancer Survivor Study Analysis Concept Proposal

Childhood Cancer Survivor Study Analysis Concept Proposal Childhood Cancer Survivor Study Analysis Concept Proposal Title: Health outcomes among survivors of adolescent and young adult cancer in the Childhood Cancer Survivor Study. Working Group and Investigators:

More information

Late effects, health status and quality of life after hemopoietic stem cell

Late effects, health status and quality of life after hemopoietic stem cell Late effects, health status and quality of life after hemopoietic stem cell transplantation (HSCT) THE 13th ESH-EBMT TRAINING COURSE ON BLOOD AND MARROW TRANSPLANTATION EBMT Slide template Barcelona 7

More information

The treatment of childhood cancer is one of the great

The treatment of childhood cancer is one of the great A Review of Secondary Central Nervous System Tumors After Treatment of a Primary Pediatric Malignancy Asher M. Marks, MD,* and Roger J. Packer, MD,,, Despite remarkable strides in the treatment of pediatric

More information

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy Stephanie Yap, M.D. University Gynecologic Oncology Northside Cancer Institute Our Learning Objectives Review survival rates,

More information

Physical Issues Cancer Survivors Face and Interventions for Improved Physical Well-Being

Physical Issues Cancer Survivors Face and Interventions for Improved Physical Well-Being Physical Issues Cancer Survivors Face and Interventions for Improved Physical Well-Being Kevin C. Oeffinger, MD Director, Duke Center for Onco-Primary Care Director, Duke Cancer Supportive Care and Survivorship

More information

Information Services Division NHS National Services Scotland

Information Services Division NHS National Services Scotland Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland

More information

Lipoplatin monotherapy for oncologists

Lipoplatin monotherapy for oncologists Lipoplatin monotherapy for oncologists Dr. George Stathopoulos demonstrated that Lipoplatin monotherapy against adenocarcinomas of the lung can have very high efficacy (38% partial response, 43% stable

More information

03/14/2019. GnRH Analogs for Fertility Preservation: What are the Data? Educational Objectives. Outline

03/14/2019. GnRH Analogs for Fertility Preservation: What are the Data? Educational Objectives. Outline GnRH Analogs for Fertility Preservation: What are the Data? AHN-JH SKCCC Current Topics in Breast Cancer Symposium Karen Lisa Smith MD MPH Assistant Professor Johns Hopkins Breast and Cancer Program March

More information

REPRODUCTIVE HEALTH IN YOUNG ADULT CANCER SURVIVORS

REPRODUCTIVE HEALTH IN YOUNG ADULT CANCER SURVIVORS REPRODUCTIVE HEALTH IN YOUNG ADULT CANCER SURVIVORS Laxmi A Kondapalli, MD MSCE Colorado Center for Reproductive Medicine Disclosure The speaker has no financial or other conflict of interest Objectives

More information

Professor Maurice Tubiana

Professor Maurice Tubiana Professor Maurice Tubiana The French way of life Dr. Odile Schweisguth Pediatric Radiation Oncology Daniele Sarrazin Pediatric Radiation Oncology Stanford Visitors from France A Massiot 1958 Courbevoie

More information

Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010

Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010 Prophylactic Cranial Irradiation in Acute Lymphoblastic Leukemia: Is there still an indication? Celine Bicquart, MD Radiation Medicine May 5, 2010 Outline Epidemiology Risk-groups Background & Rationale

More information

Melanoma-What Every Woman Need to Know about Fertility and Pregnancy

Melanoma-What Every Woman Need to Know about Fertility and Pregnancy Melanoma-What Every Woman Need to Know about Fertility and Pregnancy Women diagnosed with melanoma may require counseling for fertility preservation, fertility treatment and safety of pregnancy after treatment.

More information

Second primary cancers in adults after radiotherapy an epidemiological review

Second primary cancers in adults after radiotherapy an epidemiological review Second primary cancers in adults after radiotherapy an epidemiological review Article 31 Group meeting Radiation induced long-term health effects after medical exposure Luxembourg, 19 November 2013 Mark

More information

11/27/2017. Proton Therapy for Brain Tumors: Hope or Hype? Financial Disclosures. Objectives. None

11/27/2017. Proton Therapy for Brain Tumors: Hope or Hype? Financial Disclosures. Objectives. None Proton Therapy for Brain Tumors: Hope or Hype? 1 Financial Disclosures None 2 Objectives Discuss the rationale and evidence for proton therapy in children and adults Discuss the late effects that can be

More information

10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States.

10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States. The purview of pediatrics includes the growth, development, and health of the child and therefore begins in the period before birth when conception is apparent. It continues through childhood and adolescence

More information

THE EORTC-GELA TREATMENT STRATEGY IN CLINICAL STAGES I-II HL Results of the H9-F and H9-U trials (#20982)

THE EORTC-GELA TREATMENT STRATEGY IN CLINICAL STAGES I-II HL Results of the H9-F and H9-U trials (#20982) EORTC Lymphoma Group THE EORTC-GELA TREATMENT STRATEGY IN CLINICAL STAGES I-II HL Results of the H9-F and H9-U trials (#20982) J. Thomas, C. Fermé, E.M. Noordijk, H. Eghbali and M. Henry-Amar 7th International

More information

Cancer Risk. Klaus-Rüdiger Trott Università degli Studi di Pavia And University College London Cancer Isntitue and Technische Universität München

Cancer Risk. Klaus-Rüdiger Trott Università degli Studi di Pavia And University College London Cancer Isntitue and Technische Universität München Cancer Risk Klaus-Rüdiger Trott Università degli Studi di Pavia And University College London Cancer Isntitue and Technische Universität München The aims of Radiation Protection The aims of Radiation Protection

More information

Background. Background. AYA Overview. Epidemiology of AYA Cancers in Texas

Background. Background. AYA Overview. Epidemiology of AYA Cancers in Texas Texas Cancer Registry: Who We Are Epidemiology of AYA Cancers in Texas Melanie Williams, Ph.D. Texas Cancer Registry Cancer Epidemiology and Surveillance Branch Texas Department of State Health Services

More information

Person-Centred Perspective Indicators in Canada:

Person-Centred Perspective Indicators in Canada: Person-Centred Perspective Indicators in Canada: A REFERENCE REPORT Adolescents and Young Adults with Cancer Adolescents and Young Adults with Cancer Section 1. Adolescent and Young Adult Cancer by the

More information

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident

Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Subspecialty Inpatient Rotation: Pediatric Oncology at Memorial Sloan Kettering Cancer Center Senior Resident Residents: Pediatric residents at the PL3 level Prerequisites: Successful completion or waiver

More information

Long-term risk of second malignancy after treatment of Hodgkin s disease: the influence of treatment, age and follow-up time

Long-term risk of second malignancy after treatment of Hodgkin s disease: the influence of treatment, age and follow-up time Original article Annals of Oncology 13: 1786 1791, 2002 DOI: 10.1093/annonc/mdf289 Long-term risk of second malignancy after treatment of Hodgkin s disease: the influence of treatment, age and follow-up

More information

CLIC Sargent Eligibility Criteria

CLIC Sargent Eligibility Criteria 1 Eligibility Criteria DOCUMENT GOVERNANCE: Eligibility criteria Produced by J. Hawkins & Grants Team Sponsored by Dara de Burca Version Approval by Executive Team 10 th June 2014 Board of Trustees 3 rd

More information

WHAT ARE PAEDIATRIC CANCERS

WHAT ARE PAEDIATRIC CANCERS WHAT ARE PAEDIATRIC CANCERS INTRODUCTION Childhood cancers are RARE 0.5% of all cancers in the West Overall risk that a child will develop cancer during first 15 years of life is 1 in 450 and 1 in 600

More information

Molecular Imaging in the Development of Cancer Therapeutics. Johannes Czernin

Molecular Imaging in the Development of Cancer Therapeutics. Johannes Czernin Molecular Imaging in the Development of Cancer Therapeutics Johannes Czernin Ahmanson Biological Imaging Division University of California Los Angeles Cancer Statistics Cancer Type 5-year Survival Rate

More information

Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors

Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors Kevin C. Oeffinger, MD, 1 ; Melissa M. Hudson, MD 2 Dr. Oeffinger is Professor,

More information

Radiation Related Second Cancers. Stephen F. Kry, Ph.D., D.ABR.

Radiation Related Second Cancers. Stephen F. Kry, Ph.D., D.ABR. Radiation Related Second Cancers Stephen F. Kry, Ph.D., D.ABR. Objectives Radiation is a well known carcinogen Atomic bomb survivors Accidental exposure Occupational exposure Medically exposed Radiotherapy

More information

Information Services Division NHS National Services Scotland

Information Services Division NHS National Services Scotland Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland

More information

Cancer Survivors How to Avoid Lost in Transition

Cancer Survivors How to Avoid Lost in Transition Cancer Survivors How to Avoid Lost in Transition Ronald L Forehand, MD Medical Director, University Health, UGA Clinical Assist Professor, Ga Regents Univ Captain, MC, United States Navy (RET) Lillian

More information

Minesh Mehta, Northwestern University. Chicago, IL

Minesh Mehta, Northwestern University. Chicago, IL * Minesh Mehta, Northwestern University Chicago, IL Consultant: Adnexus, Bayer, Merck, Tomotherapy Stock Options: Colby, Pharmacyclics, Procertus, Stemina, Tomotherapy Board of Directors: Pharmacyclics

More information

Establishing a Survivorship Program Within a Large Academic Medical Center

Establishing a Survivorship Program Within a Large Academic Medical Center Establishing a Survivorship Program Within a Large Academic Medical Center Andrew J. Ward FNP-BC Surgical Oncology, The University of Tennessee Medical Center Disclosures I have no disclosures. Program

More information

Primary Care Approach to Genetic Cancer Syndromes

Primary Care Approach to Genetic Cancer Syndromes Primary Care Approach to Genetic Cancer Syndromes Jason M. Goldman, MD, FACP FAU School of Medicine Syndromes Hereditary Breast and Ovarian Cancer (HBOC) Hereditary Nonpolyposis Colorectal Cancer (HNPCC)

More information

Matthew J. Ehrhardt John T. Sandlund

Matthew J. Ehrhardt John T. Sandlund CCSS Analysis Concept Proposal Study Title: Risk for late effects of treatment in children newly diagnosed with mature B-cell non-hodgkin lymphoma: a report from the Childhood Cancer Survivor Study cohort

More information

A tumor profile and adapted cancer surveillance in Down syndrome

A tumor profile and adapted cancer surveillance in Down syndrome A tumor profile and adapted cancer surveillance in Down syndrome Daniel Satgé Pathology, University Hospital, Saint Etienne, France and ONCODEFI Project IURC Montpellier, France Michel Vekemans Labratory

More information

Member, St. Jude Children s Research Hospital (senior author)

Member, St. Jude Children s Research Hospital (senior author) Title: Physical Functioning and Chronic Health Conditions in Pediatric Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma Survivors Treated with Contemporary Therapy Working Group of Investigators:

More information

7/1/2015. Objectives. Host Factors LATE EFFECTS OF RADIOTHERAPY IN CHILDHOOD CANCER. Chronic Conditions in Adult Survivors

7/1/2015. Objectives. Host Factors LATE EFFECTS OF RADIOTHERAPY IN CHILDHOOD CANCER. Chronic Conditions in Adult Survivors LATE EFFECTS OF RADIOTHERAPY IN CHILDHOOD CANCER ARNOLD C. PAULINO, M.D. PROFESSOR DEPARTMENT OF RADIATION ONCOLOGY MD ANDERSON CANCER CENTER Objectives At the end of the presentation, the participant

More information

Disclosures 5/13/2013. Principles and Practice of Radiation Oncology First Annual Cancer Rehabilitation Symposium May 31, 2013

Disclosures 5/13/2013. Principles and Practice of Radiation Oncology First Annual Cancer Rehabilitation Symposium May 31, 2013 Principles and Practice of Radiation Oncology First Annual Cancer Rehabilitation Symposium May 31, 2013 Josh Yamada MD FRCPC Department of Radiation Oncology Memorial Sloan Kettering Cancer Center Disclosures

More information